Vinge advises Active Biotech on rights offering

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.

Vinge has advised Boliden in connection with a directed share issue of SEK 3.75 billion

Vinge has advised Boliden AB in connection with a directed share issue through which the company raises proceeds of approximately SEK 3.75 billion before transaction costs.

Vinge advises EQT on its EUR 890 million sale of Dellner Couplers to Wabtec

Vinge together with Milbank advises the EQT VIII fund (“EQT”) on its sale of Dellner Couplers (“Dellner”), a leading provider of train connection systems for passenger rail, to Wabtec Corporation (a fortune 500 company listed on the New York Stock Exchange, NYSE: WAB). The transaction values Dellner at approximately EUR 890 million. The transaction is subject to customary conditions and regulatory approvals.